Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: Stage-by-stage comparison

Urologia Internationalis

Volumn 84, Issue 1, 2010, Pages 50-55

  Moussa, S ^a   Yafi, F A ^a   El Hakim, A ^a   Fahmy, N ^a   Aprikian, A ^a   Tanguay, S ^a   Anidjar, M ^a   Kassouf, W ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Bladder; Carcinoma; Kidney; Recurrence, carcinoma; Ureter; Urothelium

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BIOLOGY; CALCULATION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LOWER URINARY TRACT UROTHELIAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UPPER URINARY TRACT UROTHELIAL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; ALGORITHMS; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETER; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 77649172750     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000273466     Document Type: Article

References (22)

1. Munoz JJ, Ellison LM: Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000; 164: 1523-1525.
2. Ozsahin M, Zouhair A, Villa S, et al: Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 1999; 35: 738-743.
3. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 677-685. (Pubitemid 23051366)
4. Kirkali Z, Tuzel E: Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003; 47: 155-169. (Pubitemid 36945314)
5. Gupta R, Paner GP, Amin MB: Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol 2008; 15: 127-139.
6. Mazeman E: Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol 1976; 2: 120-126.
7. McNeill SA, Chrisofos M, Tolley DA: The long-term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy. BJU Int 2000; 86: 619-623.
8. Hall MC, Womack S, Sagalowsky AI, et al: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52: 594-601.
9. Auld CD, Grigor KM, Fowler JW: Histopathological review of transitional cell carcinoma of the upper urinary tract. Br J Urol 1984; 56: 485-489.
10. Huben RP, Mounzer AM, Murphy GP: Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988; 62: 2016-2020.
11. Stewart GD, Bariol SV, Grigor KM, et al: A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 2005; 95: 791-793.
12. Catto JW, Yates DR, Rehman I, et al: Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007; 177: 1715-1720.
13. Akdogan B, Dogan HS, Eskicorapci SY, et al: Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006; 176: 48-52.
14. Yafi FA, Steinberg J, Kassouf W: Contemporary management of muscle-invasive bladder cancer. Int J Clin Oncol 2008; 13: 504-509.
15. Grossman HB, Natale RB, Tangen CM, et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-866.
16. Sherif A, Rintala E, Mestad O, et al: Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -Nordic cystectomy trial 2. Scand J Urol Nephrol 2002; 36: 419-425.
17. International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-urinary Group, Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group and Club Urologico Espanol de Tratamiento Oncologico (CUETO) group: Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 1999; 354: 533-540.
18. Advanced Bladder Cancer (ABC) Metaanalysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-205.
19. Freiha F, Reese J, Torti FM: A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495-499.
20. Stockle M, Meyenburg W, Wellek S, et al: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 1992; 148: 302-306.
21. Skinner DG, Daniels JR, Russell CA, et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-464.
22. Advanced Bladder Cancer (ABC) Metaanalysis Collaboration: Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-201.